Dr. Salsitz's presentation and discussion about gabapentinoids was very helpful today. I have a couple questions: 1. Striving to keep patients at or under 1800mg/day of gabapentin is a useful guideline. Is there any benefit in QID vs TID dosing? 2. To assist with appropriate monitoring of patients, do you recommend pill counts? Is a quantitative urine level useful (therapeutic vs toxic levels) or is it just to confirm they are taking it? Thank you!